Why Men Over 40 Lose Testosterone, Hair, and Energy (It's Not Aging Alone)

Bottom line: Men’s health after 40 follows predictable biological timelines: testosterone drops ~1% per year (Baltimore Longitudinal Study of Aging), growth hormone output declines 14% per decade, and androgenetic alopecia affects roughly 50% of men by age 50 (American Hair Loss Association). These declines are interconnected—low testosterone accelerates sarcopenia, declining growth hormone increases visceral fat, and hair loss progresses alongside hormonal shifts. Evidence-based treatments exist for each pathway, and telehealth has made them accessible without in-person clinic visits. The most effective approach combines diagnostic testing, lifestyle optimization, and targeted medical interventions based on confirmed deficits.

Last updated: June 2026 — Updated with 2025-2026 clinical data on hormone therapy outcomes and telehealth prescribing trends.

---

Why Does Men’s Health Change After 40?

Men’s health after 40 changes because four interconnected biological systems—testosterone, growth hormone, NAD+, and DHT-driven hair loss—decline simultaneously, creating a cascade effect that accelerates aging. Low growth hormone reduces IGF-1, which decreases muscle protein synthesis. Low testosterone reduces motivation and energy, which decreases physical activity, accelerating muscle loss. Poor sleep—common with low GH—raises cortisol, which further suppresses testosterone. These four systems decline together, not in isolation, starting in the late 30s to early 40s. According to the Baltimore Longitudinal Study of Aging, this interconnected decline explains why men experience multiple symptoms simultaneously rather than isolated issues.

What Are the Four Hormonal Systems That Decline After 40?

System	Decline Rate	Primary Impact	Age of Onset	2025/2026 Evidence
Testosterone	~1% per year after 30	Muscle mass, libido, bone density	30-40	Endocrine Society 2025 guidelines confirm threshold
Growth hormone	14% per decade after 25	Recovery, sleep quality, fat metabolism	35-45	Journal of Clinical Endocrinology & Metabolism 2025 meta-analysis
NAD+	50% drop between 40-60	Cellular energy, cognition, DNA repair	40-50	Cell Metabolism 2025 longitudinal cohort study
DHT-driven hair loss	Progressive	Scalp hair follicle miniaturization	20-40 (genetic)	American Hair Loss Association 2025 prevalence update

For a detailed breakdown of men’s health conditions: see our men’s health treatments 2026 guide.

---

What Happens to Testosterone Levels After 40?

Testosterone drops roughly 1% per year after age 30, per the Baltimore Longitudinal Study of Aging. The Endocrine Society’s 2025 clinical practice guidelines recommend testosterone replacement therapy (TRT) only for men with confirmed hypogonadism—total testosterone below 300 ng/dL on two morning measurements—combined with consistent symptoms like low libido, fatigue, or reduced muscle mass. According to the Journal of Clinical Endocrinology & Metabolism’s 2025 meta-analysis, approximately 30% of men over 40 have total testosterone below 400 ng/dL, though only 10-15% meet the clinical threshold for hypogonadism.

Clinical Thresholds

Category	Total Testosterone (ng/dL)	Free Testosterone (pg/mL)	2025 Guideline Source
Optimal	500-900	15-25	Endocrine Society 2025
Low-normal	300-500	9-15	Endocrine Society 2025
Hypogonadal	<300	<9	Endocrine Society 2025

Symptoms of Low Testosterone

• Reduced libido and erectile function
• Decreased muscle mass and strength
• Increased body fat, especially visceral
• Low energy and motivation
• Depressed mood and irritability
• Reduced bone density
• Sleep disturbances

What Causes Testosterone to Decline Faster in Some Men?

Testosterone declines faster in men with obesity, chronic stress, poor sleep, and metabolic syndrome. According to the Journal of Clinical Endocrinology & Metabolism’s 2025 meta-analysis, men with a BMI over 30 experience testosterone levels 15-20% lower than lean counterparts at the same age. Visceral fat converts testosterone to estrogen through aromatase activity, creating a feedback loop that accelerates decline. The American Diabetes Association’s 2025 position paper notes that men with type 2 diabetes have testosterone levels approximately 25% lower than age-matched controls.

For more on hormone therapy: see our testosterone replacement therapy guide.

---

What Happens to Growth Hormone After 40, and Does Sermorelin Help?

Growth hormone production peaks in the mid-20s and declines approximately 14% per decade thereafter—by age 50, most men produce roughly half the growth hormone they did at 25. Sermorelin, a growth hormone-releasing hormone (GHRH) analog, stimulates the pituitary to produce more of its own growth hormone rather than replacing it directly, which is why it doesn’t suppress natural production the way synthetic HGH does. According to Alba et al. in the Journal of Clinical Endocrinology & Metabolism (2005), Sermorelin therapy increased IGF-1 levels by 40-60% in clinical trials, restoring levels to those typical of a decade earlier without the side effects of exogenous HGH. The 2025 update from the Journal of Clinical Endocrinology & Metabolism’s meta-analysis confirmed that Sermorelin’s IGF-1 elevation effect is consistent across age groups, with a 45-55% average increase in IGF-1 levels over 12 weeks of therapy.

How Does Sermorelin Compare to Synthetic HGH?

Therapy	Mechanism	IGF-1 Increase	Natural Production Preserved	Side Effect Profile
Sermorelin	Stimulates pituitary GHRH receptors	40-60% (Alba 2005; corroborated by JCEM 2025 meta-analysis)	Yes	Mild injection site reactions
Synthetic HGH	Direct replacement	50-80%	No—suppresses natural production	Joint pain, edema, carpal tunnel, insulin resistance

What Are the Benefits of Sermorelin Therapy for Men Over 40?

Sermorelin therapy improves sleep quality, body composition, and recovery time. According to the Journal of Clinical Endocrinology & Metabolism’s 2025 meta-analysis, men using Sermorelin for 12 weeks reported a 30% improvement in sleep quality scores and a 2-4% reduction in body fat percentage. The therapy also increases lean muscle mass by 3-5% over 6 months, per the same analysis. These effects are attributed to Sermorelin’s stimulation of natural growth hormone pulses, which occur primarily during deep sleep.

For the full evidence review: see our sermorelin guide.

---

What Is NAD+ and Why Does It Decline After 40?

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme essential for mitochondrial energy production and DNA repair. Levels decline approximately 50% between ages 40 and 60, according to Cell Metabolism’s 2025 longitudinal cohort study. This decline accelerates cellular aging by reducing the efficiency of sirtuins—proteins that regulate cellular repair and inflammation. The 2025 Nature Reviews molecular biology update confirmed that NAD+ depletion is a hallmark of aging, directly linked to reduced mitochondrial function and increased oxidative stress.

NAD+ Effects

Function	Impact of Low NAD+	Evidence	2025/2026 Update
Mitochondrial energy	Fatigue, reduced exercise capacity	Cell Metabolism (2020); corroborated by Cell Metabolism 2025 cohort study	2025 study confirms 50% decline between 40-60
DNA repair	Accelerated cellular aging	Nature Reviews (2021); corroborated by Nature Reviews 2025 update	2025 update confirms sirtuin dysfunction
Cognitive function	Brain fog, reduced focus	Translational Psychiatry (2022); corroborated by Neurology 2025 trial	2025 trial shows NAD+ precursors improve cognitive scores
Metabolic health	Insulin resistance, weight gain	Diabetes Care (2021); corroborated by Diabetes Care 2025 position paper	2025 paper links NAD+ to glucose metabolism

What Are the Treatment Options for Low NAD+?

NAD+ therapy options include intravenous infusions, intramuscular injections, and oral precursors like nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN). According to Cell Metabolism’s 2025 cohort study, intravenous NAD+ infusions increase blood NAD+ levels by 200-300% within 24 hours, while oral NR increases levels by 40-60% over 4 weeks. The American Academy of Anti-Aging Medicine’s 2025 clinical guidance recommends NAD+ injections for men with confirmed low NAD+ levels and symptoms of fatigue or cognitive decline.

For NAD+ therapy details: see our NAD+ therapy 60-day test and NAD+ anti-aging guide.

---

What Causes Hair Loss After 40 and How Is It Treated?

Androgenetic alopecia affects approximately 50% of men by age 50 and 70% by age 70, per American Hair Loss Association 2025 prevalence data. The mechanism is DHT binding to hair follicle receptors, causing follicle miniaturization. According to the Journal of Investigative Dermatology’s 2025 clinical review, DHT levels in the scalp are 10-20 times higher in men with androgenetic alopecia compared to men without hair loss, even when serum DHT levels are similar.

Treatment Hierarchy

Treatment	Mechanism	Efficacy	FDA Approved	2025/2026 Evidence
Dutasteride	99% DHT blockade	20-25% hair count increase at 1 year	Off-label for hair	Journal of Dermatology 2025 trial confirms superiority
Finasteride	70% DHT blockade	15-20% hair count increase at 1 year	Yes	FDA 2025 label update confirms safety profile
Minoxidil 5%	Vasodilation, potassium channel	12-18% hair count increase at 1 year	Yes	Journal of Dermatology 2025 trial confirms efficacy
Topical copper peptides	VEGF, fibroblast activation	~14% density increase at 12 weeks	No	Journal of Cosmetic Dermatology 2025 pilot study

How Do Dutasteride and Finasteride Compare for Hair Loss?

Dutasteride blocks approximately 99% of DHT production by inhibiting both type 1 and type 2 5-alpha-reductase enzymes, while finasteride blocks approximately 70% by inhibiting only type 2. According to the Journal of Dermatology’s 2025 comparative trial, dutasteride 0.5mg daily produced a 25% hair count increase at 12 months compared to 18% for finasteride 1mg daily. The American Hair Loss Association’s 2025 clinical guidance notes that dutasteride is used off-label for hair loss in the US but is approved for this indication in South Korea and Japan.

For detailed comparison: see our dutasteride vs finasteride guide and DHT hair loss truth.

---

How Common Is Erectile Dysfunction After 40, and How Is It Treated?

ED affects 52% of men between 40 and 70 according to the Massachusetts Male Aging Study. Causes are multifactorial—vascular, hormonal, neurological, and psychological. According to the Journal of Sexual Medicine’s 2025 prevalence update, the incidence of ED increases by approximately 10% per decade after age 40, with 40% of men in their 40s reporting some degree of erectile difficulty.

What Are the Treatment Options for ED After 40?

Treatment	Mechanism	Efficacy	2025/2026 Evidence
Sildenafil (Viagra)	PDE5 inhibitor	70-80% success rate	Journal of Sexual Medicine 2025 meta-analysis
Tadalafil (Cialis)	PDE5 inhibitor	75-85% success rate	Journal of Sexual Medicine 2025 meta-analysis
Vacuum devices	Mechanical	60-70% success rate	American Urological Association 2025 guidelines
Hormone therapy	Addresses underlying cause	Variable	Endocrine Society 2025 guidelines

Telehealth platforms offer PDE5 inhibitors after online consultation. According to the Journal of Telemedicine and Telecare’s 2025 study, 85% of men who used telehealth for ED treatment reported satisfaction with the process, and 90% received their medication within 72 hours of consultation.

---

What Should a Man Over 40 Do About Hormone Decline? A 4-Step Action Plan

Start with diagnostic bloodwork to identify which systems are actually declining, build a lifestyle foundation that supports every hormone pathway at once, add targeted medical interventions only where labs confirm a deficit, and re-test to track progress.

Step 1: Diagnostic Testing

Get comprehensive bloodwork including:

• Total and free testosterone
• LH, FSH, prolactin
• IGF-1 (growth hormone marker)
• DHT levels
• Comprehensive metabolic panel
• Thyroid panel (TSH, free T4, free T3)
• Vitamin D, B12, and ferritin levels

Step 2: Lifestyle Foundation

Intervention	Frequency	Expected Impact	2025/2026 Evidence
Resistance training	3-4x/week	+15-30% acute GH response	Endocrine Society 2025 guidelines
Sleep 7-9 hours	Daily	GH release occurs in deep sleep	Journal of Clinical Endocrinology & Metabolism 2025
Protein: 1.6-2.2 g/kg	Daily	Muscle protein synthesis	American College of Sports Medicine 2025
Stress management	Daily	Cortisol reduction, T increase	Journal of Clinical Endocrinology & Metabolism 2025
Limit alcohol	<2 drinks/day	Reduced T suppression	Endocrine Society 2025 guidelines

Step 3: Medical Interventions

Based on diagnostic results and symptoms:

• Low testosterone → TRT (if confirmed <300 ng/dL)
• Low GH/IGF-1 → Sermorelin therapy
• Hair loss → Dutasteride or finasteride
• Low NAD+/energy → NAD+ injections
• ED → PDE5 inhibitors

Step 4: Ongoing Monitoring

Re-test hormone levels at 3-month intervals after starting therapy. Adjust dosing based on lab results and symptom improvement. According to the Endocrine Society’s 2025 guidelines, men on TRT should have testosterone levels checked every 3-6 months, with hematocrit and PSA monitoring annually.

---

How Do Men Access Hormone and Hair Loss Treatment Online?

US telehealth platforms have restructured how men access prescription treatments—a free online assessment replaces the in-person specialist visit, with physician review typically completed within 24 hours and prescriptions shipped directly. According to the Journal of Telemedicine and Telecare’s 2025 study, telehealth consultations for hormone therapy increased by 300% between 2020 and 2025, with 75% of men reporting satisfaction with the remote care model.

What Are the Leading Telehealth Platforms for Men’s Health?

Platform	Services	Pricing (2026)	Physician Review Time
Strut Health	Sermorelin, TRT, NAD+, hair loss, ED	Sermorelin $79/month, sexual health $101/month, NAD+ $103/month, Dutasteride $79/month	24 hours
Platform B	TRT, ED	TRT $99-199/month	48 hours
Platform C	Hair loss, ED	Finasteride $25-50/month	24 hours

Pricing example (Strut Health, a Verto affiliate partner): Sermorelin $79/month, men’s sexual health program $101/month, NAD+ injections $103/month, Dutasteride hair loss treatment $79/month.

For the full Strut Health review: see our men’s health treatments 2026 guide.

---

What Are the Risks and Side Effects of Hormone Therapy for Men Over 40?

Hormone therapy carries specific risks that men should discuss with their physician before starting. According to the Endocrine Society’s 2025 clinical practice guidelines, TRT may increase hematocrit levels, requiring periodic blood donation or dose adjustment in 10-15% of men. Sermorelin therapy has minimal side effects—primarily injection site reactions in 5-10% of users, per the Journal of Clinical Endocrinology & Metabolism’s 2025 meta-analysis. Dutasteride and finasteride carry a 1-2% risk of sexual side effects, including decreased libido and erectile dysfunction, though these typically resolve upon discontinuation, according to the Journal of Dermatology’s 2025 trial.

How Do Men Mitigate These Risks?

Regular bloodwork monitoring every 3-6 months identifies potential issues early. According to the Endocrine Society’s 2025 guidelines, men on TRT should have hematocrit checked at 3 months and annually thereafter. Men using DHT blockers should monitor for mood changes and sexual function, with dose adjustment or discontinuation if side effects persist beyond 3 months.

---